About Myrexis (OTCMKTS:MYRX)
Myrexi, Inc. is a development-stage company. The Company was a biopharmaceutical company that generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. In February 2012, it announced that the Company has suspended development activity on all of its preclinical and clinical programs and retained Stifel Nicolaus Weisel, an investment banking firm, to assist in reviewing and evaluating a full range of strategic alternatives to enhance shareholder value. The Company determines to pursue the acquisition of one or more commercial-stage biopharmaceutical assets, with the goal of building a commercial-stage biopharmaceutical company. The Company operates in pharmaceutical development and related research activities. The Company’s revenues were derived from research performed in the United States and, all of the Company’s long-lived assets are located in the United States.
Industry, Sector and Symbol
Industry Drugs - Generic
Trailing P/E Ratio-0.112857142857143
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Myrexis (OTCMKTS:MYRX) Frequently Asked Questions
What is Myrexis' stock symbol?
Myrexis trades on the OTCMKTS under the ticker symbol "MYRX."
Who are some of Myrexis' key competitors?
Who are Myrexis' key executives?
Myrexis' management team includes the folowing people:
- Jonathan M. Couchman, President, Chief Executive Officer, Chief Financial Officer, Director (Age 45)
- Andrea Kendell, Treasurer, Secretary (Age 40)
- Michael Cooper Pearce, Independent Director (Age 51)
- Steven D. Scheiwe, Independent Director (Age 55)
How do I buy Myrexis stock?
Shares of Myrexis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Myrexis' stock price today?
One share of Myrexis stock can currently be purchased for approximately $0.05.
How big of a company is Myrexis?
Myrexis has a market capitalization of $1.63 million.
How can I contact Myrexis?
Myrexis' mailing address is 630 5th Ave Ste 2260, NEW YORK, NY 10111-2291, United States. The biopharmaceutical company can be reached via phone at +1-801-2147800 or via email at [email protected]
MarketBeat Community Rating for Myrexis (MYRX)MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Myrexis (OTCMKTS:MYRX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Myrexis (OTCMKTS:MYRX) Earnings History and Estimates Chart
Myrexis (OTCMKTS MYRX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Myrexis (OTCMKTS:MYRX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Myrexis (OTCMKTS:MYRX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Myrexis (OTCMKTS MYRX)
No insider trades for this company have been tracked by MarketBeat.com
Myrexis (OTCMKTS MYRX) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Myrexis (OTCMKTS:MYRX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Myrexis (OTCMKTS:MYRX) Income Statement, Balance Sheet and Cash Flow Statement
Myrexis (OTCMKTS MYRX) Stock Chart for Sunday, February, 25, 2018